-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-women-treatment_executive.pdf
August 01, 2012 - Uncertainty exists about the
choice between PCI and CABG for patients with moderate
CAD burden; namely
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cad-women-treatment_executive.pdf
August 01, 2012 - Uncertainty exists about the
choice between PCI and CABG for patients with moderate
CAD burden; namely
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2.pdf
January 01, 2022 - CBDa THC Synthetic THC
THC to CBD Ratio Unclear High High
Source Any cannabis product
(patient’s choice … 1,514
4-year followup: 1,217
Groups unclear
4 years
Unclear THC
concentration; patient-
driven choice … authorization for
medical cannabis in
Canada (5,373)
20 months
Unknown THC
concentration; patient-
driven choice … month use of
marijuana (65)
C: No use (313)
52 weeks
Unknown THC
concentration; patient-
driven choice
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/cer-250-cannabis-apps-a-e-surveillance-report-2.pdf
January 01, 2022 - CBDa THC Synthetic THC
THC to CBD Ratio Unclear High High
Source Any cannabis product
(patient’s choice … 1,514
4-year followup: 1,217
Groups unclear
4 years
Unclear THC
concentration; patient-
driven choice … authorization for
medical cannabis in
Canada (5,373)
20 months
Unknown THC
concentration; patient-
driven choice … month use of
marijuana (65)
C: No use (313)
52 weeks
Unknown THC
concentration; patient-
driven choice
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2-final.pdf
February 01, 2022 - CBDa THC Synthetic THC
THC to CBD Ratio Unclear High High
Source Any cannabis product
(patient’s choice … 1,514
4-year followup: 1,217
Groups unclear
4 years
Unclear THC concentration;
patient-driven choice … authorization for
medical cannabis in Canada
(5,373)
20 months
Unknown THC
concentration; patient-driven
choice … month use of marijuana (65)
C: No use (313)
52 weeks
Unknown THC
concentration; patient-driven
choice
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/cer-250-cannabis-apps-a-e-surveillance-report-2-final.pdf
March 01, 2022 - CBDa THC Synthetic THC
THC to CBD Ratio Unclear High High
Source Any cannabis product
(patient’s choice … 1,514
4-year followup: 1,217
Groups unclear
4 years
Unclear THC concentration;
patient-driven choice … authorization for
medical cannabis in Canada
(5,373)
20 months
Unknown THC
concentration; patient-driven
choice … month use of marijuana (65)
C: No use (313)
52 weeks
Unknown THC
concentration; patient-driven
choice
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/cer-250-cannabis-surveillance-report-3.pdf
May 01, 2022 - CBDa THC Synthetic THC
THC to CBD Ratio Unclear High High
Source Any cannabis product
(patient’s choice … 1,514
4-year followup: 1,217
Groups unclear
4 years
Unclear THC
concentration; patient-
driven choice … authorization for
medical cannabis in
Canada (5,373)
20 months
Unknown THC
concentration; patient-
driven choice … month use of
marijuana (65)
C: No use (313)
52 weeks
Unknown THC
concentration; patient-
driven choice
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2-final_0.pdf
March 01, 2022 - CBDa THC Synthetic THC
THC to CBD Ratio Unclear High High
Source Any cannabis product
(patient’s choice … 1,514
4-year followup: 1,217
Groups unclear
4 years
Unclear THC concentration;
patient-driven choice … authorization for
medical cannabis in Canada
(5,373)
20 months
Unknown THC
concentration; patient-driven
choice … month use of marijuana (65)
C: No use (313)
52 weeks
Unknown THC
concentration; patient-driven
choice
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3.pdf
May 01, 2022 - CBDa THC Synthetic THC
THC to CBD Ratio Unclear High High
Source Any cannabis product
(patient’s choice … 1,514
4-year followup: 1,217
Groups unclear
4 years
Unclear THC
concentration; patient-
driven choice … authorization for
medical cannabis in
Canada (5,373)
20 months
Unknown THC
concentration; patient-
driven choice … month use of
marijuana (65)
C: No use (313)
52 weeks
Unknown THC
concentration; patient-
driven choice
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3_0.pdf
May 01, 2022 - CBDa THC Synthetic THC
THC to CBD Ratio Unclear High High
Source Any cannabis product
(patient’s choice … 1,514
4-year followup: 1,217
Groups unclear
4 years
Unclear THC
concentration; patient-
driven choice … authorization for
medical cannabis in
Canada (5,373)
20 months
Unknown THC
concentration; patient-
driven choice … month use of
marijuana (65)
C: No use (313)
52 weeks
Unknown THC
concentration; patient-
driven choice
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2-final_0_0.pdf
March 01, 2022 - CBDa THC Synthetic THC
THC to CBD Ratio Unclear High High
Source Any cannabis product
(patient’s choice … 1,514
4-year followup: 1,217
Groups unclear
4 years
Unclear THC concentration;
patient-driven choice … authorization for
medical cannabis in Canada
(5,373)
20 months
Unknown THC
concentration; patient-driven
choice … month use of marijuana (65)
C: No use (313)
52 weeks
Unknown THC
concentration; patient-driven
choice
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3_0.pdf
May 01, 2022 - CBDa THC Synthetic THC
THC to CBD Ratio Unclear High High
Source Any cannabis product
(patient’s choice … 1,514
4-year followup: 1,217
Groups unclear
4 years
Unclear THC
concentration; patient-
driven choice … authorization for
medical cannabis in
Canada (5,373)
20 months
Unknown THC
concentration; patient-
driven choice … month use of
marijuana (65)
C: No use (313)
52 weeks
Unknown THC
concentration; patient-
driven choice
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2-final_0_0.pdf
March 01, 2022 - CBDa THC Synthetic THC
THC to CBD Ratio Unclear High High
Source Any cannabis product
(patient’s choice … 1,514
4-year followup: 1,217
Groups unclear
4 years
Unclear THC concentration;
patient-driven choice … authorization for
medical cannabis in Canada
(5,373)
20 months
Unknown THC
concentration; patient-driven
choice … month use of marijuana (65)
C: No use (313)
52 weeks
Unknown THC
concentration; patient-driven
choice
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/obesity-child_executive.pdf
March 31, 2010 - 1
Comparative Effectiveness Review
Number 115
Childhood Obesity Prevention Programs:
Comparative Effectiveness Review
and Meta-Analysis
Executive Summary
Background
The epidemic of childhood obesity
is threatening America’s children.1-3
Overweight children and adolescents
are at greater risk for health pr…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/obesity-child_executive.pdf
March 31, 2010 - 1
Comparative Effectiveness Review
Number 115
Childhood Obesity Prevention Programs:
Comparative Effectiveness Review
and Meta-Analysis
Executive Summary
Background
The epidemic of childhood obesity
is threatening America’s children.1-3
Overweight children and adolescents
are at greater risk for health pr…
-
digital.ahrq.gov/sites/default/files/docs/page/CongressionalBudgetOffice.pdf
January 01, 2009 - The EHR might also have a feature that
could suggest a drug that might be a better choice,
given
-
cds.ahrq.gov/sites/default/files/cds/artifact/1071/Implementation%20Guide_Healthful%20Diet%20and%20Physical%20Activity_Final_0.pdf
September 01, 2021 - expressions like this artifact can use the tool to develop new CDS logic in the clinical domain of
their choice … and their primary
healthcare clinician to determine together the most appropriate treatment or care choice
-
cds.ahrq.gov/sites/default/files/cds/artifact/1061/IG%20Abnormal%20Blood%20Glucose%20Type%202%20DM%20Screening.pdf
September 01, 2021 - expressions like this artifact can use the tool to develop new CDS logic in the clinical domain of
their choice … and their primary
healthcare clinician to determine together the most appropriate treatment or care choice
-
www.ahrq.gov/sites/default/files/publications/files/cuspsuccess.pdf
October 01, 2012 - insertion and maintenance
9
bundles, daily rounding, educating new nurses, bimonthly IV classes, choice … Being only 30 minutes from
Nashville and its choice of hospitals, he was acutely aware that “we have
-
cds.ahrq.gov/sites/default/files/cds/artifact/1061/508_2022_CDS_Connect_IG_T2DM_Part_One_Screening_final.pdf
January 01, 2022 - developing CDS
logic expressions can use the tool to develop new CDS logic in the clinical domain of their
choice … and their primary
healthcare clinician to determine together the most appropriate treatment or care choice